NCT00999011

Brief Summary

This study will examine the effects of once and twice daily activity performed with patients who are breathing with the aid of a machine in an intensive care unit. Activity can occur in bed. Activity can include transfer to a chair and even walking once the patient's condition allows safe, out-of-bed activity. The investigators hypothesize that early, progressive activity will reduce inflammatory molecules in the blood, promote muscle and physical health and help patients to recover more quickly from critical illness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 21, 2009

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

2.1 years

First QC Date

October 20, 2009

Last Update Submit

March 29, 2022

Conditions

Keywords

critical careinflammatory biomarkerscytokinesmechanical ventilationactivitymobility therapyMore than 48 hours of mechanical ventilation

Outcome Measures

Primary Outcomes (17)

  • Change in molecular biomarkers of inflammation day 1 of intervention

    IL-6, IL-10, C-reactive protein.

    1 day

  • Change in molecular biomarkers of inflammation day 2 of intervention if patient still in ICU

    IL-6, IL-10, C-reactive protein.

    1 day

  • Change in molecular biomarkers of inflammation day 3 of intervention if patient still in ICU

    IL-6, IL-10, C-reactive protein.

    1 day

  • Vital Signs included RR, HR, and SBP. Change in Respiratory Rate day 1 of intervention.

    Change is Respiratory rate (RR),measured in breaths per minute, during the intervention and comparing to baseline (rest) only.

    Baseline = time during rest immediately preceding the intervention. Intervention = 30 min of activity

  • Change in Respiratory Rate day 2 of intervention if patient still in ICU. Heart Rate and Systolic Blood Pressure. Each vital sign is measured separately and not aggregated.

    Breaths per minute as recorded on the bedside monitor Change defined as the difference between RR at rest and highest RR during the intervention.

    Baseline RR = time during rest immediately preceding the intervention. Intervention RR = 30 min activity

  • Change in Respiratory Rate day3 of intervention if patient still in ICU.

    Breaths per minute as recorded on the bedside monitor Change defined as the difference between RR at rest and RR duriing activity.

    Baseline RR = time during rest immediately preceding the intervention. Intervention RR= during 30 min of activity

  • Vital Signs. Change in Heart Rate day 1 of intervention

    Change in Heart rate (HR), measured in beats per minute, during the intervention only comparing to baseline. The bedside ICU monitor was used.

    ring rest immediately preceding the intervention. Outcome = highest and lowest values during the mobility intervention.

  • Change in Heart Rate day 2 of intervention if patient still in ICU

    Change in Heart rate (HR), measured in beats per minute, during the intervention only comparing to baseline. The bedside ICU monitor was used.

    Once daily or twice daily for up to 3 days of intervention. Baseline = time during rest immediately preceding the intervention. Outcome = highest and lowest values during the mobility intervention.

  • Change in Heart Rate day 3 if patient still in ICU

    Change in Heart rate (HR), measured in beats per minute, during the intervention only comparing to baseline. The bedside ICU monitor was used.

    Once daily or twice daily for up to 3 days of intervention. Baseline = time during rest immediately preceding the intervention. Outcome = highest and lowest values during the mobility intervention.

  • Vital Signs , Change in Systolic Blood Pressure day 1

    Change in SBP, measured inmmHg, during the intervention only comparing to baseline. The bedside ICU monitor was used. The highest and lowest values were recorded for analysis. The largest change from baseline rest were used in analysis (Rest - Highest value obtained during intervention. This was done 3 times (once daily for up to 3 days) if randomized to once daily interventions or up to 6 times if randomized to twice daily intervention over 3 days.

    Once daily or twice daily for up to 3 days of intervention. Baseline = time during rest immediately preceding the intervention. Outcome = highest and lowest values during the mobility intervention.

  • Vital Signs. Change in Systolic Blood Pressure day 2 of intervention if patient still in ICU

    Change in Systolic blood pressure (SBP), measured in millimeters of mercury (mmHg) during the intervention comparing to baseline. The bedisde ICU monitor was used if an arterial indwelling line was present. An automatic BP cuff (dynometer) was used at the start and every 5 minutes if an indwelling line was used. The highest and lowest values were recorded during the intervention.

    Once daily or twice daily for up to 3 days on intervention. Baseline = time during rest immediately preceding the intervention Outcome = highest and lowest values during the mobility intervention.

  • Change in Systolic Blood Pressure Day 3 of intervention if patient still in ICU

    Change in Systolic blood pressure (SBP), measured in millimeters of mercury (mmHg) during the intervention comparing to baseline. The bedisde ICU monitor was used if an arterial indwelling line was present. An automatic BP cuff (dynometer) was used at the start and every 5 minutes if an indwelling line was used. The highest and lowest values were recorded during the intervention.

    Once daily or twice daily for up to 3 days on intervention. Baseline = time during rest immediately preceding the intervention Outcome = highest and lowest values during the mobility intervention.

  • The total number of days of Mechanical Ventilation while in the ICU

    . This is a one-time value. This is the total number of days the patient received invasive mechanical ventilation as documented in the record.

    Measured one time, at the discharge from the ICU

  • Muscle strength day 1

    This was measured with hand grip using a dynometer and reported as dynes or kg of force.

    Measured once after the intervention on day 1. Collected as many as 3 times if the patient received 3 days of intervention

  • Muscle strength day 2

    This was measured with hand grip using a dynometer and reported as dynes or kg of force.

    Measured once after the intervention. Collected as many as 3 times if the patient received 3 days of intervention

  • Muscle strength day 3

    This was measured with hand grip using a dynometer and reported as dynes or kg of force.

    Measured once after the intervention. Collected as many as 3 times if the patient received 3 days of intervention

  • Change in muscle strength

    This was defined as the difference in dynes from Day 1 to Day 3, if the patient was in the ICU for 3 days, or the change from Day 1 to 2 if in the ICU for only 2 days

    Collected once after the interention on days 1, 2, 3. The maximum potential change was defined as Day 1-Day 3 but Day 1 -Day was used for patients who were discharged from the ICU on Day 2 and had no data for Day 3

Study Arms (2)

One 20 minute period of activity daily

ACTIVE COMPARATOR

passive and/or active range of motion, chair sitting, sitting at edge of bed, standing and walking

Procedure: once daily mobility activity

Two periods of 20 minute activity daily

ACTIVE COMPARATOR

passive and/or active range of motion, chair sitting, sitting at edge of bed, standing and walking

Procedure: twice daily mobility activity

Interventions

in bed and out-of-bed activity including range of motion, chair sitting, sitting at edge of bed without weightbearing, standing, walking.

One 20 minute period of activity daily

as with once daily. Goal is to progress intensity and duration of activity over time as patient condition improves for both arms

Two periods of 20 minute activity daily

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients who require invasive mechanical ventilation for more than 24 continuous hours in the surgical (SICU) or medical ICU (MICU)
  • a P:F ratio \> 100
  • FiO2 \< 60% and PEEP less than 10 cmH20 at baseline

You may not qualify if:

  • Patients for high risk of death will also be excluded, using criteria established by Norton et al.: ICU admission following a hospital stay of \>9 days in the past 12 months; age \>80 in the presence of 2 or more life-threatening illnesses (e.g., end-stage renal disease, severe heart failure (HF); diagnosis of an active stage IV malignancy; status post cardiac arrest; and diagnosis of intracerebral hemorrhage requiring mechanical ventilation.\[99\].
  • Subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Frances Payne Bolton School of Nursing Case Western Reserve University

Cleveland, Ohio, 44106, United States

Location

Related Publications (1)

  • Winkelman C, Sattar A, Momotaz H, Johnson KD, Morris P, Rowbottom JR, Thornton JD, Feeney S, Levine A. Dose of Early Therapeutic Mobility: Does Frequency or Intensity Matter? Biol Res Nurs. 2018 Oct;20(5):522-530. doi: 10.1177/1099800418780492. Epub 2018 Jun 14.

MeSH Terms

Conditions

Critical IllnessMotor Activity

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Chris Winkelman, PhD

    Case Western Reserve University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 20, 2009

First Posted

October 21, 2009

Study Start

May 1, 2009

Primary Completion

June 1, 2011

Study Completion

March 1, 2013

Last Updated

March 31, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations